Slovenia to launch generic version of Viagra

Jul 31, 2009

Krka, the biggest drugmaker in Slovenia, said Friday that its generic version of the impotency drug Viagra would be launched in September and priced 30 percent cheaper than the original.

"We'll launch it first in Slovenia and later on, when the patents expire in other countries (in 2012), we'll offer it in central, eastern and western Europe as well," Krka chief executive Joze Colaric told the Internet news site, Zurnal24.

Russia, in particular, was seen as an important market.

Krka's version of the erectile dysfunction drug would be marketed under the name "vizarsin" and, unlike the blue pills made by US drug giant , would be white in colour, Colaric said.

The European Medicines Agency EMEA authorised the marketing of Krka's generic version of on June 25.

(c) 2009 AFP

Explore further: Bangladesh jails three over drug scam that killed hundreds of children (Update)

add to favorites email to friend print save as pdf

Related Stories

AIDS group objects to Viagra ads

Dec 14, 2006

An AIDS advocacy group in Los Angeles has asked the makers of Viagra to cease a marketing campaign that appears to promote the drug's recreational use.

European office withdraws Nexium patent

Dec 21, 2006

The European Patent Office, answering a generic drug maker's challenge, withdrew a patent on Britain-based AstraZeneca PLC's heartburn treatment, Nexium.

Viagra may aggravate sleep apnea

Sep 25, 2006

A study done in Brazil indicates a single dose of the erectile dysfunction drug Viagra may aggravate sleep apnea.

Cialis may have one-a-day version

Jun 13, 2006

U.S. drug giants Eli Lilly and Icos Corp. plan to seek regulatory approval to market a one-a-day version of their impotence-fighting drug Cialis.

Viagra sales don't meet expectations

May 20, 2007

While sales of erectile dysfunction drugs like Viagra have been steady since their release, their popularity has not met expectations, the Miami Herald said.

Recommended for you

Journal raises concern about blood-thinning drug

10 hours ago

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

Supermaterial gives rejected drugs a new chance

Jul 22, 2014

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Risk of antibiotic overuse in aged care settings

Jul 21, 2014

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

User comments : 0